Kevetrin is also where I'm putting my chips on. There maybe others out there that have something as good in the works, but I try to stick to what I think I know.
So let me ask you this; Do you think by JPM Conference we will get from management a indication of p21 expression out of cohorts 5 and 6 ? If not, do you think Cohort 7 with 120mg could show p-53 activation ?
If CTIX is going ahead with with B Phase 2b alone before accepting a partnership, will that be so bad?
Or, should they do the ole "play against each other" on the two Pharmas they signed a NDA with and get the best partnership deal they can get NOW on B and stop the dilution and get that resulting pop in tpps and a uplist perhaps to NASDAQ ?
And while they are at it, they should then just come out and show us why they been hiding Waldo in 200 ft. of a LLC.
(Inquiring minds would like to know)
Thank You for you views and observations.
-bunny-
So let me ask you this; Do you think by JPM Conference we will get from management a indication of p21 expression out of cohorts 5 and 6 ? If not, do you think Cohort 7 with 120mg could show p-53 activation ?
If CTIX is going ahead with with B Phase 2b alone before accepting a partnership, will that be so bad?
Or, should they do the ole "play against each other" on the two Pharmas they signed a NDA with and get the best partnership deal they can get NOW on B and stop the dilution and get that resulting pop in tpps and a uplist perhaps to NASDAQ ?
And while they are at it, they should then just come out and show us why they been hiding Waldo in 200 ft. of a LLC.
(Inquiring minds would like to know)
Thank You for you views and observations.
-bunny-